Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine
Yale University
Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
VA Office of Research and Development
A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
Psychiatric University Hospital, Zurich
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
Massachusetts General Hospital
Ketamine for Depression and Suicide Risk
Mayo Clinic
Ketamine in Adolescents With Treatment-Resistant Depression
University of Minnesota
Biomarkers of Fast Acting Therapies in Major Depression
University of California, Los Angeles
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
Janssen Research & Development, LLC
Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
NYU Langone Health
Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy
University of Saskatchewan
Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
Yale University
Ketamine Plus Lithium in Treatment-Resistant Depression
Icahn School of Medicine at Mount Sinai
Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
Massachusetts General Hospital
A Study of Ketamine in Patients With Treatment-resistant Depression
Janssen Research & Development, LLC
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Janssen Research & Development, LLC
PET Imaging of mGLuR5 With Drug Challenge
Yale University
Ketamine in the Treatment of Suicidal Depression
New York State Psychiatric Institute
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
University of Alabama at Birmingham
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
Massachusetts General Hospital
Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
University Hospital, Grenoble
Ketamine for Depression and Alcohol Dependence
Yale University
Ketamine in the Treatment of Depression
Columbia University
Intranasal Ketamine in Treatment-Resistant Depression
James Murrough
MRI Studies of Emotion in Depression
Icahn School of Medicine at Mount Sinai
Ketamine Anesthesia in Electroconvulsive Therapy
Mayo Clinic
The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy
University of Aberdeen
Neuromodulation to Facilitate the Effect of Ketamine
The Neuroscience Center, LLC
Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Northwell Health
Ketamine for Low Mood States in the ER
Yale University
Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
AstraZeneca
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Dennis Charney
Continuation Ketamine in Major Depression
James Murrough
Memantine Augmentation of Antidepressants
University of Massachusetts, Worcester
Rapid Antidepressant Effects of Ketamine in Major Depression
National Institute of Mental Health (NIMH)
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Cybin IRL Limited
Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Psyrin Inc.
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
University of Pittsburgh
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Yale University
Long Term Follow Up KET-PD
Yale University
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
Kernel
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Indiana University
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
Sunnybrook Health Sciences Centre
Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe Depression
Chinese PLA General Hospital
Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression
Chinese PLA General Hospital
Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
Federal University of São Paulo
Ketamine for Combined Depression and Alcohol Use Disorder
University Hospital of North Norway
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.